Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

New study investigates how green tea could lead to a drug for tackling Covid-19

As India continues to be ravaged by the pandemic, a Swansea University academic is investigating how green tea could give rise to a drug capable of tackling Covid-19.

5 Jun 2021

COVID-19 has had a detrimental impact on adolescent mental health, study finds

A study of over 59,000 Icelandic adolescents by a team of Icelandic and North American behavioral and social scientists found that COVID-19 has had a significant, detrimental impact on adolescent mental health, especially in girls.

5 Jun 2021

Georgia State professor receives federal grant to study seasonal and universal vaccination in elderly populations

Dr. Sang-Moo Kang, professor in the Institute for Biomedical Sciences at Georgia State University, has received a five-year, $2.7 million federal grant to study seasonal and universal vaccination in elderly populations with pre-existing immunity to influenza viruses.

5 Jun 2021

Mason researchers examine the potential anti-coronavirus activities of an over-the-counter drink

Could an over-the-counter health "shot" help fight COVID-19? George Mason University researchers think it just might.

5 Jun 2021

Study finds no genetic evidence to prove vitamin D protects against coronavirus

While previous research early in the pandemic suggested that the vitamin D cuts the risk of contracting COVID-19, a new study from McGill University finds there is no genetic evidence that the vitamin works as a protective measure against the coronavirus.

5 Jun 2021

First human case of H10N3 influenza reported in Jiangsu, China

As the coronavirus disease (COVID-19) pandemic continues to spread and wreak havoc globally, another health threat emerged in China. The country has reported its first confirmed case of the rare H10N3 bird flu in a patient admitted to the hospital in April 2021 in Zhenjiang, China.

4 Jun 2021

Risk of SARS-CoV-2 spread to bats

A recent bioRxiv* preprint offers a powerful risk assessment approach to estimate the risk of bat exposure to SARS-CoV-2 from humans during their interactions in the wild.

4 Jun 2021

In Missouri and other states, flawed data makes it hard to track vaccine equity

Throughout the covid-19 vaccination effort, public health officials and politicians have insisted that providing shots equitably across racial and ethnic groups is a top priority.

4 Jun 2021

Analysis: Mounting pressure on China about Covid ‘lab leak’ could backfire

President Joe Biden has ordered U.S. intelligence agencies to determine whether the Covid virus, or a near ancestor, emerged from a cave, a live-animal market, a farm — or a secretive Chinese laboratory.

4 Jun 2021

Post-COVID-19 assessment shows long-lasting consequences for many non-hospitalized individuals

Complications following COVID-19 infection require quick identification and management to help plan policy and health system responses. Researchers in the UK recently described the 12-month experience of the first dedicated post-COVID clinical service in the UK to include both hospitalized and non-hospitalized COVID-19 patients. This study has been released on the medRxiv* the preprint server.

4 Jun 2021

Mental health effects common among mild and severe cases of COVID-19

Findings on mental health outcomes of COVID-19 infection show frequent symptoms associated with lasting neurological symptoms.

4 Jun 2021

Potential transmission for Kawasaki disease unexpectedly uncovered due to COVID-19

Pandemic prevention measures have been associated with lower rates of Kawasaki disease in children across South Korea.

4 Jun 2021

Another symptom of the COVID-19 pandemic: unhealthy eating

In a study of 2,000 people, researchers found that the recent abrupt change in our daily routines caused us to change our eating behaviors.

4 Jun 2021

A lack of oversight for unproven stem cell interventions is a global public health problem

Authors are urging the WHO to establish an Exert Advisory Committee on Regenerative Medicine to provide harmony to the national regulations on the SCI industry.

4 Jun 2021

Waters launches new RUO LC-MS test method to advance infectious disease research

Waters Corporation today introduced a new RUO LC-MS test method to advance critical infectious disease research.

4 Jun 2021

Researchers report how the tobacco and e-cigarette industry capitalized on COVID-19 to promote smoking

Scientific papers suggesting that smokers are less likely to fall ill with covid-19 are being discredited as links to the tobacco industry, reveals an investigation by The BMJ today.

4 Jun 2021

Novel insights can open doors to combating clotting-related problems in COVID-19

Researchers scour what is known to come up with a hypothesis of why blood clots can be a major problem in COVID-19

4 Jun 2021

Study brings to light the role of a cellular protein in COVID-19 infections

Angiotensin-converting enzyme 2 (ACE2), a protein found on the surface of lung cells, facilitates the entry of the novel coronavirus into host cells.

4 Jun 2021

Clinical trial evaluating mixed COVID-19 vaccine schedules begins at NIH

Vaccination efforts against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus behind the coronavirus disease (COVID-19) pandemic, are well underway in many countries. Over 2 billion vaccines have been administered to date, and campaigns continue to encourage more people to get vaccinated.

4 Jun 2021

World Health Organization simplifies names of SARS-CoV-2 variants

Now, the World Health Organization (WHO) has assigned simple and easy-to-say labels for key variants of SARS-CoV-2 using letters of the Greek alphabet. The health agency selected these labels after a thorough review of many potential naming systems.

4 Jun 2021

Pandemic News and Research

Further Reading

New study investigates how green tea could lead to a drug for tackling Covid-19

COVID-19 has had a detrimental impact on adolescent mental health, study finds

Georgia State professor receives federal grant to study seasonal and universal vaccination in elderly populations

Mason researchers examine the potential anti-coronavirus activities of an over-the-counter drink

Study finds no genetic evidence to prove vitamin D protects against coronavirus

First human case of H10N3 influenza reported in Jiangsu, China

Risk of SARS-CoV-2 spread to bats

In Missouri and other states, flawed data makes it hard to track vaccine equity

Analysis: Mounting pressure on China about Covid ‘lab leak’ could backfire

Post-COVID-19 assessment shows long-lasting consequences for many non-hospitalized individuals

Mental health effects common among mild and severe cases of COVID-19

Potential transmission for Kawasaki disease unexpectedly uncovered due to COVID-19

Another symptom of the COVID-19 pandemic: unhealthy eating

A lack of oversight for unproven stem cell interventions is a global public health problem

Waters launches new RUO LC-MS test method to advance infectious disease research

Researchers report how the tobacco and e-cigarette industry capitalized on COVID-19 to promote smoking

Novel insights can open doors to combating clotting-related problems in COVID-19

Study brings to light the role of a cellular protein in COVID-19 infections

Clinical trial evaluating mixed COVID-19 vaccine schedules begins at NIH

World Health Organization simplifies names of SARS-CoV-2 variants

Best practices - optimize qPCR processes for pathogen detection eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News